Pediatric Chordoma: A Tale of Two Genomes.


Journal

Molecular cancer research : MCR
ISSN: 1557-3125
Titre abrégé: Mol Cancer Res
Pays: United States
ID NLM: 101150042

Informations de publication

Date de publication:
01 May 2024
Historique:
accepted: 26 04 2024
received: 13 09 2023
revised: 23 02 2024
medline: 1 5 2024
pubmed: 1 5 2024
entrez: 1 5 2024
Statut: aheadofprint

Résumé

Little is known regarding the genomic alterations in chordoma, with the exception of loss of SMARCB1, a core member of the SWI/SNF complex, in poorly differentiated chordomas. A TBXT duplication and rs2305089 polymorphism, located at 6q27, are known genetic susceptibility loci. A comprehensive genomic analysis of the nuclear and mitochondrial genomes in pediatric chordoma has not yet been reported. In this study, we performed whole exome and mitochondrial DNA (mtDNA) genome sequencing on 29 chordomas from 23 pediatric patients. Findings were compared with that from whole genome sequencing datasets of 80 adult skull base chordoma patients. In the pediatric chordoma cohort, 81% percent of the somatic mtDNA mutations were observed in NADH complex genes, which is significantly enriched compared to the rest of the mtDNA genes (p=0.001). In adult chordomas, mtDNA mutations were also enriched in the NADH complex genes (p<0.0001). Furthermore, a progressive increase in heteroplasmy of non-synonymous mtDNA mutations was noted in patients with multiple tumors (p=0.0007). In the nuclear genome, rare likely germline in-frame indels in ARID1B, a member of the SWI/SNF complex located at 6q25.3, were observed in five pediatric patients (22%) and four patients in the adult cohort (5%). The frequency of rare ARID1B indels in the pediatric cohort is significantly higher than that of the adult cohort (p=0.0236, Fisher's exact test), but they were both significantly higher than that in the ethnicity-matched populations (p<5.9e-07 and p<0.0001174, respectively). Implications: germline ARID1B indels and mtDNA aberrations appear important for chordoma genesis, especially in pediatric chordoma.

Identifiants

pubmed: 38691518
pii: 745133
doi: 10.1158/1541-7786.MCR-23-0741
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Katrina O'Halloran (K)

Children's Hospital of Los Angeles, Los Angeles, United States.

Hesamedin Hakimjavadi (H)

Children's Hospital of Los Angeles, Los Angeles, CA, United States.

Moiz Bootwalla (M)

Children's Hospital of Los Angeles, United States.

Dejerianne Ostrow (D)

Children's Hospital of Los Angeles, Los Angeles, CA, United States.

Rhea Kerawala (R)

Children's Hospital of Los Angeles, United States.

Jennifer A Cotter (JA)

Children's Hospital of Los Angeles, Los Angeles, CA, United States.

Venkata Yellapantula (V)

Children's Hospital of Los Angeles, United States.

Kristiyana Kaneva (K)

Tempus Labs (United States), United States.

Nitin R Wadhwani (NR)

Northwestern University, Feinberg School of Medicine, Chicago, IL, United States.

Amy Treece (A)

Children's Hospital Colorado, United States.

Nicholas K Foreman (NK)

University of Colorado Denver, Aurora, United States.

Sanda Alexandrescu (S)

Boston Children's Hospital, Boston, MA, United States.

Jose Velazquez Vega (J)

Children's Healthcare of Atlanta, United States.

Jaclyn A Biegel (JA)

Children's Hospital of Los Angeles, Los Angeles, CA, United States.

Xiaowu Gai (X)

Children's Hospital of Los Angeles, Los Angeles, CA, United States.

Classifications MeSH